University Hospital Mainz
Welcome,         Profile    Billing    Logout  
 66 Trials 
109 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neumann, Helmut
NCT04339855: AI for Colorectal Polyp Detection in Endoscopy

Active, not recruiting
N/A
600
Europe
CAD with LCI for colorectal polyp detection
Johannes Gutenberg University Mainz
Focus of the Study is to Evaluate a New Developed Deep-learning Computer-aided Detection System in Combination With LCI for Colorectal Polyp Detection
08/20
09/20
NCT04457934: Effectiveness of PLENVU in the General Screening Population and Patients With IBD

Recruiting
N/A
290
Europe
Plenvu
Johannes Gutenberg University Mainz
IBD, Healthy
01/21
08/21
NCT04456231: QR Code for Endoscopic Bowel Preparation

Recruiting
N/A
404
Europe
Plenvu
Johannes Gutenberg University Mainz
Quality Standards in Colonoscopy, Patient Education, Acceptance of Bowel-preparation
01/21
06/21
NCT04734912: Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Recruiting
N/A
500
Europe
gastroscopy in transnasal techique
Johannes Gutenberg University Mainz
Endoscopy
06/21
12/21
COLOWISE, NCT05611151: Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy

Completed
N/A
830
Europe, US
Computer Aided Detection (CADe)
NEC Corporation, Meditrial Europe Ltd., Meditrial USA Inc.
Colorectal Cancer, Adenoma Colon, Polyp of Colon
09/24
09/24
Fuji AI, NCT04894708: Study on the Use of Artificial Intelligence (Fujifilm) for Polyp Detection in Colonoscopy

Recruiting
N/A
1572
Europe
colonoscopy
Universitätsklinikum Hamburg-Eppendorf, FUJIFILM Deutschland, Branch office of FUJIFILM Europe GmbH
Screening Colonoscopy, Colonoscopic Control After Polypectomy, Suspected Colon Polyps
05/24
09/24
Hess, Georg
BRUIN-MCL-321, NCT04662255 / 2020-004553-72: Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Active, not recruiting
3
500
Europe, Canada, Japan, US, RoW
Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib, Imbruvica, Acalabrutinib, Calquence, Zanubrutinib, Brukinsa
Loxo Oncology, Inc., Eli Lilly and Company
Lymphoma, Mantle-Cell
12/25
07/26
BRUIN CLL-322, NCT04965493 / 2021-000043-49: A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Recruiting
3
600
Europe, Canada, Japan, US, RoW
Pirtobrutinib, LOXO-305, LY3527727, Venetoclax, Venclexta, Venclyxto, Rituximab, Rituxan, MabThera, Truxima, Riabni, Ruxience
Loxo Oncology, Inc., Eli Lilly and Company
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
04/26
01/27
SYMPHONY-1, NCT04224493 / 2019-003333-42: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Jan 2023 - Dec 2023: DOR/PFS data from P1b portion of P1b/3 SYMPHONY-1 trial in combination with Revlimid and Rituxan for relapsed/refractory follicular lymphoma
Hourglass Jan 2023 - Dec 2023 : First interim futility data from P3 portion of P1b/3 SYMPHONY-1 trial in combination with Rituxan for relapsed/refractory follicular lymphoma
Hourglass Jan 2022 - Dec 2022 : Completion of enrollment of P3 portion of P1b/3 trial for r/r follicular lymphoma
Checkmark Data from SYMPHONY-1 trial in combination with Rituxan and Revlimid for follicular lymphoma
Jun 2022 - Jun 2022: Data from SYMPHONY-1 trial in combination with Rituxan and Revlimid for follicular lymphoma
More
Recruiting
3
612
Europe, Canada, US, RoW
Tazemetostat, EPZ-6438, IPN60200, Placebo oral tablet, Lenalidomide, Rituximab
Epizyme, Inc.
Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma
03/26
03/29
CARMAN, NCT06482684: CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

Recruiting
2
150
Europe
KTE-X19, Ibrutinib
Christian Schmidt, MD, Johannes Gutenberg University Mainz
Mantle Cell Lymphoma
06/31
12/31
Treede, Hendrik
BIOVALVE, NCT02249000: - I / II Clincial Investigation

Completed
N/A
68
Europe
BIOVALVE prosthesis
Biotronik AG, Medstar Health Research Institute
Heart Valve Diseases, Aortic Valve Stenosis
03/18
05/23
NCT02732691: JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

Active, not recruiting
N/A
68
Europe, US, RoW
JenaValve Pericardial TAVR System
JenaValve Technology, Inc.
Aortic Valve Stenosis, Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Ventricular Outflow Obstruction
05/19
04/24
TAVIS, NCT05536310: Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

Not yet recruiting
N/A
600
Europe
Transcatheter Aortic Valve Implantation (TAVI)
JenaValve Technology, Inc.
Aortic Valve Stenosis, Aortic Valve Regurgitation, Aortic Valve Stenosis With Insufficiency, Constriction, Pathologic, Aortic Valve Disease, Heart Valve Diseases, Cardiovascular Diseases in Old Age, Ventricular Outflow Obstruction, Aortic Stenosis, Severe
10/23
10/27
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
ARTIST, NCT06608823: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

Not yet recruiting
N/A
1016
NA
Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System, SAVR
JenaValve Technology, Inc.
Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
02/26
02/36
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial

Recruiting
N/A
650
Europe, Canada, Japan, US, RoW
Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)
Medtronic Cardiovascular
Moderate Aortic Valve Stenosis
02/26
12/34
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial

Recruiting
N/A
400
Europe
Medtronic Intrepid™ TMVR TF System
Medtronic Cardiovascular
Mitral Regurgitation
08/29
12/38
Gori, Tommaso
QUOMODO, NCT04808310: QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions

Completed
4
200
Europe
Quantitative flow ratio, Assessment of angiographic severity of the stenosis
Johannes Gutenberg University Mainz
Coronary Artery Disease
04/23
04/24
FAIR-HF2, NCT03036462 / 2016-000068-40: Intravenous Iron in Patients with Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

Completed
4
1105
Europe
Iron, Saline, salin
Universitätsklinikum Hamburg-Eppendorf, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Charite University, Berlin, Germany
Systolic Heart Failure, Iron Deficiency
05/24
05/24
EXAMINE-CAD, NCT05294887: Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease

Recruiting
4
132
Europe
Bisoprolol, beta blocker, Diltiazem, Placebo
Charite University, Berlin, Germany, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary, Vasospastic Angina, Prinzmetal Angina, Coronary Artery Disease
06/24
06/24
EPIDAURUS, NCT04981041: Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

Recruiting
4
2334
Europe
Prasugrel or Ticagrelor, Clopidogrel
Ludwig-Maximilians - University of Munich
Acute Coronary Syndrome, Atrial Fibrillation
12/24
06/25
PICIO, NCT04417634: RFR and FFR for the the Prediction of Post-PCI Results

Recruiting
4
100
Europe
RFR, FFR
Johannes Gutenberg University Mainz
Coronary Artery Disease
06/25
06/25
NCT05437900: INSIGHTFUL-FFR Clinical Trial

Recruiting
4
2500
Europe, RoW
Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care
CoreAalst BV, Insight Lifetech Co., Ltd.
Coronary Artery Disease, Acute Coronary Syndrome
06/26
06/30
DECIPHER-HFpEF, NCT03251183: Validation of CMR Against Invasive Haemodynamics in Patients With HFpEF

Completed
N/A
185
Europe
Comprehensive Cardiovascular magnetic resonance (CMR), Blood sampling, TTE (EchoErgo), Invasive pressure-volume (PV) Loops, Left ventricular (LV) biopsy
Goethe University, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Heart Failure With Normal Ejection Fraction
12/22
12/22
MACCHUS, NCT05034224: Coronary Sinus Pressure and Microvascular Disease

Completed
N/A
20
Europe
Swan-Ganz catheter placed in the coronary sinus - deflated, Swan-Ganz catheter placed in the coronary sinus - inflated
Johannes Gutenberg University Mainz
Microvascular Coronary Artery Disease
08/23
08/23
MICAT, NCT02180178: Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

Recruiting
N/A
1000
Europe
observational only- no intervention
Johannes Gutenberg University Mainz
Coronary Artery Disease, Microvascular Dysfunction
09/28
09/28
TIPTAP-I, NCT03714750: Treatment of Coronary Bifurcation Lesions: Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting

Completed
N/A
50
Europe
DK crush, Reverse TAP
Tommaso Gori
Coronary Artery Disease
04/24
04/24
MicroFAME, NCT04612322: MICRO: a Registry Study in Patients With Microvascular Angina

Recruiting
N/A
1000
Europe
Assessment of microvascular function with intracoronary hemodilution
Johannes Gutenberg University Mainz
Microvascular Disease
10/24
10/29
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
COSIMA, NCT04606459: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Recruiting
N/A
144
Europe
Coronary sinus reducer, Optimal medical therapy
Johannes Gutenberg University Mainz, Neovasc Inc.
Coronary Microvascular Disease, Refractory Angina
10/25
10/29
ASPERA-ANOCA, NCT06269874: Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment

Not yet recruiting
N/A
40
Europe
microvascular function assessment
Johannes Gutenberg University Mainz
Microvascular Coronary Artery Disease
07/27
08/27
MICRO-SNAPE, NCT06125392: Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition

Recruiting
N/A
1000
Europe
Coronary physiology assessment, Parameters of coronary physiology in response to microvascular vasodilators (adenosine, papaverine) and acetylcholine
Johannes Gutenberg University Mainz
Coronary Microvascular Disease, Coronary Vasospasm
08/28
08/28
Schuster, Michael
LIBERAL, NCT03369210: Liberal Transfusion Strategy in Elderly Patients

Recruiting
3
2470
Europe
red blood cell transfusion trigger
Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital
Transfusion-dependent Anemia, Surgery, Anemia
12/24
12/25
FORMULA-OLS, NCT03583164 / 2017-001290-17: Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Completed
2
203
Europe, US, RoW
Olorofim, F901318
F2G Biotech GmbH, Iqvia Pty Ltd
Invasive Fungal Infections
02/23
02/23
ASC2ESCALATE, NCT05384587: Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

Active, not recruiting
2
196
US
asciminib, ABL001
Novartis Pharmaceuticals
Chronic Myelogenous Leukemia - Chronic Phase
09/25
10/27
iinnovate-3, NCT05590377 / 2022-002169-14: A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Completed
1/2
15
Europe, Canada, US, RoW
Modakafusp Alfa, TAK-573, Daratumumab
Takeda, Takeda Development Center Americas, Inc.
Multiple Myeloma
05/24
05/24
DREAMM 12, NCT04398745: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function

Recruiting
1
36
Europe, US, RoW
Belantamab mafodotin, GSK2857916
GlaxoSmithKline
Multiple Myeloma
02/25
02/25
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
N/A
99999
US
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program
Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia
10/41
10/41
Bardeleben, Ralph Von
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
Reshape-HF2, NCT02444338: A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

Completed
N/A
505
Europe, RoW
MitraClip, standard of care
University Medical Center Goettingen, University Medical Center Goettingen
Mitral Valve Insufficiency
04/24
04/24
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC

Recruiting
N/A
2650
Europe, Canada, Japan, US, RoW
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
08/27
08/30
CHOICE-MI, NCT04688190: CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

Recruiting
N/A
800
Europe, Canada, US, RoW
Universitätsklinikum Hamburg-Eppendorf, Montreal Heart Institute, University Hospital, Bordeaux
Mitral Regurgitation
03/25
12/30
RESOLVE-MR, NCT04818502: Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation

Active, not recruiting
N/A
200
Europe, RoW
Tendyne™ Mitral Valve System, Transcatheter Mitral Valve Implantation (TMVI)
Abbott Medical Devices
Mitral Valve Regurgitation
05/25
05/29
VANTAGE, NCT04788888: Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Recruiting
N/A
590
Europe, RoW
Navitor Transcatheter Aortic Valve and FlexNav Delivery System
Abbott Medical Devices
Symptomatic Severe Aortic Stenosis
06/25
02/36
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial

Recruiting
N/A
400
Europe
Medtronic Intrepid™ TMVR TF System
Medtronic Cardiovascular
Mitral Regurgitation
08/29
12/38
Schattenberg, Jörn M
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
NAFLD-TRF, NCT05220956: Impact of Time-restricted Feeding in NAFLD

Recruiting
N/A
100
Europe
Intermittent fasting, Time restricted feeding, DGE diet
Johannes Gutenberg University Mainz, University of Turin, Italy
Fatty Liver Disease, Fatty Liver, Fatty Liver, Nonalcoholic
09/24
12/24
PBC-Cohort, NCT04076527 / 2016-004141-90: Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis

Recruiting
N/A
1200
Europe
UDCA, ursodeoxycholic acid, Ocaliva, obeticholic acid
University of Leipzig, RWTH Aachen University, Zentrum für Klinische Studien Leipzig, Intercept Pharma Europe Limited (IPEL), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Erlangen, Medical care center for Gastroenterology, Berlin, Institute for Interdisciplinary Medicine, Hamburg, Leberhilfe Projekt gUG, Cologne, Hannover Medical School
PBC, Primary Biliary Cholangitis
03/24
03/24
NCT04442334: The European NAFLD Registry

Recruiting
N/A
10000
Europe
Newcastle University, Newcastle-upon-Tyne Hospitals NHS Trust, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Institute of Cardiometabolism and Nutrition, France, University of Cambridge, Örebro University, Sweden, University of Bern, University of Oxford, University of Turin, Italy, University of Angers, University Hospital, Antwerp, Linkoeping University, University of Helsinki, UMC Utrecht, National and Kapodistrian University of Athens, University of Lisbon, University of Milan, University of Palermo, Catholic University of the Sacred Heart, Wuerzburg University Hospital, RWTH Aachen University, University of Nottingham, Medical University of Vienna, University of Birmingham, University of Florence, Assistance Publique - Hôpitaux de Paris, University Medical Center Mainz
NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver, Hepatocellular Carcinoma, Cardiovascular Diseases, Type 2 Diabetes, Dyslipidaemia, Hypertension, Obesity, Other Associated Comorbidities
12/30
12/30
Mieghem, Nicolas M Van
NCT05491200 / 2021-005499-20: Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Recruiting
4
1608
Europe, RoW
Prasugrel based short DAPT, Prasugrel based standard DAPT, OCT guided revascularization, Angio guided revascularization
Research Maatschap Cardiologen Rotterdam Zuid, Abbott Medical Devices
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy
08/26
08/28
REDOX TAVI, NCT04171726: Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

Recruiting
3
100
Europe
Edoxaban
Erasmus Medical Center, Daiichi Sankyo, Inc.
Aortic Valve Stenosis
06/23
09/23
SURTAVI, NCT01586910: Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement ().

Active, not recruiting
N/A
1746
Europe, Canada, US
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR), Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic Cardiovascular
Severe Aortic Stenosis
07/18
11/26
NCT04147884: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Active, not recruiting
N/A
4
US, RoW
Millipede Transcatheter Annuloplasty Ring System (Millipede System)
Boston Scientific Corporation
Mitral Regurgitation Functional, Mitral Valve Disease, Cardiovascular Diseases
12/21
11/26
THRONE, NCT04052256: The Heartflow Coronary Disease Progression Evaluation Study

Recruiting
N/A
250
Europe
Coronary computed tomography angiography
Erasmus Medical Center
Coronary Artery Disease
10/22
10/23
NCT03621501: Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease

Active, not recruiting
N/A
1525
Europe
Percutaneous coronary intervention, PCI
Erasmus Medical Center, Biotronik SE & Co. KG
Acute Coronary Syndrome
10/22
10/26
PLUTO-II, NCT06204783: Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions

Recruiting
N/A
157
Europe
Pressure volume (PV) loop measurement
Erasmus Medical Center
Heart Failure, Valvular Heart Disease, Aortic Stenosis, Mitral Insufficiency, Tricuspid Insufficiency
05/24
05/25
POLESTAR, NCT03910751: Trial - An International Multi-center Early Discharge TAVI Program

Active, not recruiting
N/A
252
Europe, Canada
Transcatheter Aortic Valve Implantation with ACURATE Neo Aortic Bioprosthesis
Erasmus Medical Center, Boston Scientific Corporation
Aortic Valve Stenosis
12/22
02/24
ART-VR, NCT05069987: Anxiety Reduction in TAVI Using Virtual Reality Trial

Recruiting
N/A
150
Europe
Virtual Reality Immersion
Erasmus Medical Center
Aortic Stenosis, Severe, Anxiety
12/22
05/23
NCT04799769: Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study

Recruiting
N/A
90
Europe
Percutaneous arterial closure device
Vivasure Medical Limited
Percutaneous Arteriotomy Closure
01/23
03/23
PRECISE TAVI, NCT04473443: Addition of Computer Simulations to Minimize Adverse Events After Transcatheter Aortic Valve Implantation

Recruiting
N/A
200
Europe
FEops HEARTguideTM
Erasmus Medical Center, Feops
Aortic Valve Stenosis, Bicuspid Cardiac Valve
02/23
06/23
NCT02661451: Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Active, not recruiting
N/A
178
Europe, Canada, US
SAPIEN 3 THV, Optimal Heart Failure Therapy
Cardiovascular Research Foundation, New York, Cardialysis BV, Avania
Aortic Valve Stenosis
02/23
02/25
POTUS, NCT05374733: Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions

Recruiting
N/A
150
Europe
Coronary Physiology assessment
Erasmus Medical Center
Aortic Valve Stenosis, Mitral Regurgitation, Coronary Artery Disease, Fractional Flow Reserve
03/23
03/23
PLUTO-I, NCT05909280: Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort I: Veno-arterial Extracorporeal Membrane Oxygenation

Recruiting
N/A
20
Europe
Pressure-volume loop measurements
Erasmus Medical Center
Extracorporeal Membrane Oxygenation, Cardio/Pulm: Heart Failure
11/24
12/24
NCT06181240: Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)

Recruiting
N/A
400
Europe
Intravascular lithotripsy
Bolt Medical
Coronary Artery Disease, Coronary Artery Calcification
04/25
03/26
IABP ON-TIME, NCT06414187: Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock

Not yet recruiting
N/A
400
Europe
Intra-Aortic Balloon Pump
Erasmus Medical Center, Arrow International LCC (Subsidiary of Teleflex Inc.)
Cardiogenic Shock
06/27
06/27
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure with Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial

Active, not recruiting
N/A
527
Europe, Canada, US
Impella CP® placement prior to reperfusion with Primary PCI
Abiomed Inc.
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
09/24
10/30
PROVE, NCT05539573: ACURATE neo2™ - Post Market Safety and Performance Surveillance in Aortic Stenosis

Active, not recruiting
N/A
1043
Europe
Planned TAVI with the ACURATE neo2™ aortic bioprosthesis and ACURATE neo2™ transfemoral delivery system.
University of Leipzig, National University of Ireland, Galway
Aortic Stenosis
04/25
04/25
VANTAGE, NCT04788888: Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

Recruiting
N/A
590
Europe, RoW
Navitor Transcatheter Aortic Valve and FlexNav Delivery System
Abbott Medical Devices
Symptomatic Severe Aortic Stenosis
06/25
02/36
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
NCT05149755: Evolut™ EXPAND TAVR II Pivotal Trial

Recruiting
N/A
650
Europe, Canada, Japan, US, RoW
Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)
Medtronic Cardiovascular
Moderate Aortic Valve Stenosis
02/26
12/34
BASELINE, NCT04843072: Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis

Recruiting
N/A
400
Europe, Canada, US
Evolut R/PRO bioprosthesis, Edwards Sapien S3/Ultra bioprosthesis
Erasmus Medical Center
Valve Heart Disease
05/26
05/26
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial

Recruiting
N/A
400
Europe
Medtronic Intrepid™ TMVR TF System
Medtronic Cardiovascular
Mitral Regurgitation
08/29
12/38
SAVI-AoS, NCT04514250: Stress Aortic Valve Index for Assessing Risk in Aortic Valve Stenosis Patients

Active, not recruiting
N/A
52
Europe, US
Catharina Ziekenhuis Eindhoven
Aortic Valve Stenosis
10/24
10/28
UNLOAD-HF, NCT05064202: Unloading in Heart Failure Cardiogenic Shock

Not yet recruiting
N/A
456
Europe
Impella 5.5, Inotropes
Amsterdam UMC, location VUmc, Abiomed Inc.
Cardiogenic Shock
10/27
07/28
TRACE-NL, NCT05628779: Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation

Enrolling by invitation
N/A
150
Europe
TriClip TTVr system (Abbott Vascular), PASCAL TTVr system (Edwards Lifesciences)
St. Antonius Hospital, ZonMw: The Netherlands Organisation for Health Research and Development
Tricuspid Valve Regurgitation, Nonrheumatic, Cardiac Catheterization, Heart Failure, Right Sided, Valve Regurgitation, Tricuspid
11/27
11/27
ATLAS TAVI, NCT04914481: Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low-Flow Low-Gradient Aortic Stenosis Undergoing TAVI

Recruiting
N/A
1500
Europe, Canada, RoW
Universitätsklinikum Hamburg-Eppendorf, Institut universitaire de cardiologie et de pneumologie de Québec
Low-Flow, Low-Gradient Aortic Stenosis
12/22
12/25
Wittenmeier, Eva
LIBERAL, NCT03369210: Liberal Transfusion Strategy in Elderly Patients

Recruiting
3
2470
Europe
red blood cell transfusion trigger
Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital
Transfusion-dependent Anemia, Surgery, Anemia
12/24
12/25
Schmidt, Marcus
NeoON, NCT05036005: Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label

Recruiting
4
108
Europe
Ontruzant, SB3, Chemotherapy, Pertuzumab
Institut fuer Frauengesundheit, Samsung Bioepis Co., Ltd.
Breast Cancer, Breast Neoplasms, Breast Cancer Female, HER2-positive Breast Cancer
04/23
07/23
CAPTOR-BC, NCT05452213: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Recruiting
4
1000
Europe
Ribociclib
Institut fuer Frauengesundheit, AGO Breast Study Group e.V., Novartis Pharmaceuticals
Breast Cancer, Breast Neoplasms, Breast Neoplasm Female, Breast Cancer Female, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Advanced Breast Cancer
10/24
10/26
SASCIA, NCT04595565 / 2019-004100-35: Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

Active, not recruiting
3
1332
Europe
Capecitabine, Xeloda, Carboplatin, Paraplatin, Cisplatin, Platinol, Sacituzumab govitecan, Trodelvy
German Breast Group, Gilead Sciences, Austrian Breast & Colorectal Cancer Study Group, Spanish Breast Cancer Research Group (GEICAM), ETOP IBCSG Partners Foundation, Cancer Trials Ireland, UNICANCER
HER2-negative Breast Cancer, Triple Negative Breast Cancer
03/27
03/29
Reiser, Iris
PH002-TP-II, NCT03272477 / 2016-005157-21: Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Completed
2
257
Europe
Perjeta Injectable Product, Pertuzumab, Herceptin, Trastuzumab, Tamoxifen, Paclitaxel, Epirubicin, Cyclophosphamide, Anastrozole, Letrozole, Exemestane, Leuprorelin acetate, Goserelin, Leuporelin acetate, Biopsy, Surgery
Palleos Healthcare GmbH, Roche Pharma AG, WSG WOMEN´S HEALTHCARE STUDY GROUP, Cankado GmbH
Breast Neoplasms
07/20
03/24
neoMono, NCT04770272 / 2020-001651-40: Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy

Completed
2
416
Europe
Atezolizumab 840 MG in 14 ML Injection, Tecentriq, Atezolizumab 1200 MG in 20 ML Injection, Carboplatin, Paclitaxel, Epirubicin, Cyclophosphamide, Biopsy Arm A, Biopsy Arm B, Surgery
Palleos Healthcare GmbH, Roche Pharma AG, Phaon Scientific GmbH, University Hospital, Essen, University Hospital Erlangen
Triple-negative Breast Cancer
07/23
10/24
Verhelst, Xavier
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

Active, not recruiting
3
238
Europe, Canada, Japan, US, RoW
Linerixibat, Placebo
GlaxoSmithKline
Pruritus
10/24
01/25
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study

Recruiting
3
251
Europe, Canada, Japan, US, RoW
Linerixibat
GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited
Cholestasis
02/27
02/27
PACIFIC, NCT05525520 / 2021-002526-25: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Completed
2
62
Europe, Canada, US, RoW
EP547, Placebo
Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc.
Pruritus
07/24
09/24
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

Recruiting
2
200
Europe, Canada, US, RoW
Volixibat, SHP626, Placebo
Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc.
Primary Sclerosing Cholangitis
09/25
12/25
LEOPARD TVDCS, NCT06675604: LEOPARD Training and Validation Data Collection Study

Not yet recruiting
N/A
4500
Europe
Assistance Publique - Hôpitaux de Paris, European Society for Organ Transplantation (ESOT)-European Liver and Intestine Transplant Association (ELITA)ELITA, University Luxembourg (UNILU) - ELIXIR, Italian National Transplant Centre (CNT), La Fe University hospital Valencia (HULAFE)
Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
12/27
11/28
LEOPARD PVC1, NCT06723275: LEOPARD Prospective Validation Cohort 1

Not yet recruiting
N/A
630
Europe
Standardized assessments, guided tumor biopsy and biobanking, Standardized assessments and biobanking
Assistance Publique - Hôpitaux de Paris, University Luxembourg (UNILU) - ELIXIR, Hospital Universitario La Fe, ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (ECRIN), Ophiomics - Precision Medicine, EF CLIF, INSERM 1149, INSERM U1052
Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
01/27
10/27
COIN-B, NCT04779970 / 2019-001226-10: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections

Active, not recruiting
N/A
156
Europe
Cessation of ongoing treatment
University Hospital, Antwerp, Universiteit Antwerpen
Chronic Hepatitis B
12/25
12/25
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

Recruiting
N/A
3000
Europe, Canada, Japan, US, RoW
Observational Protocol
European Foundation for Study of Chronic Liver Failure
Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
12/25
12/26
GLYGALT, NCT05866796: Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

Recruiting
N/A
600
Europe
GlycoTransplantTest
University Hospital, Ghent, Fund for Scientific Research, Flanders, Belgium, University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Liver Transplant Failure, Prognostic Biomarkers
04/26
05/27
GLITCA, NCT05866783: Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Recruiting
N/A
500
Europe
HCCRecurrencePrognosticScore, HCCRecurrenceDiagnosticScore
University Hospital, Ghent, University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Prognostic Biomarker, Liver Transplantation, Diagnostic Biomarker, Hepatocellular Carcinoma
01/27
01/38
Wörns, Marcus-Alexander
CaboCHILD, NCT04454762: A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function

Recruiting
2
20
Europe
Cabozantinib, Cabometyx
Johannes Gutenberg University Mainz, Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz
Hepatocellular Carcinoma
08/23
02/24
Emrich, Tilman
T1Outcome-DE, NCT03749343: International T1 Multicenter Outcome Study

Recruiting
N/A
8000
Europe
Johann Wolfgang Goethe University Hospital, Kerckhoff Klinik, Johannes Gutenberg University Mainz
Heart Failure, Cardiomyopathies, Inflammatory Disease, Coronary Artery Disease, Chronic Kidney Diseases
02/30
02/30
EPIPHANY, NCT05877768: Evaluation of PCD-CT Based Image Parameters in the Assessment and Quantification of Coronary Artery Disease

Not yet recruiting
N/A
3000
Europe
Photon Counting Detector Coronary Computed Tomography Angiography, Photon-Counting Detector CT (Naeotom Alpha, Siemens Healthineers)
University Medical Center Mainz
Coronary Artery Disease
06/33
06/33
Bardeleben, Stephan von
AHEAD, NCT03339115: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System

Recruiting
N/A
30
Europe
Cardiovalve Transfemoral Mitral Valve
Cardiovalve Ltd., Meditrial Europe Ltd., Meditrial SrL
Mitral Regurgitation, Mitral Valve Disease
12/24
12/29
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
06/24
12/29
 

Download Options